Barriers and facilitators of artificial intelligence conception and implementation for breast imaging diagnosis in clinical practice: a scoping review

ObjectiveAlthough artificial intelligence (AI) has demonstrated promise in enhancing breast cancer diagnosis, the implementation of AI algorithms in clinical practice encounters various barriers. This scoping review aims to identify these barriers and facilitators to highlight key considerations for developing and implementing AI solutions in breast cancer imaging.MethodA literature search was conducted from 2012 to 2022 in six databases (PubMed, Web of Science, CINHAL, Embase, IEEE, and ArXiv). The articles were included if some barriers and/or facilitators in the conception or implementation of AI in breast clinical imaging were described. We excluded research only focusing on performance, or with data not acquired in a clinical radiology setup and not involving real patients.ResultsA total of 107 articles were included. We identified six major barriers related to data (B1), black box and trust (B2), algorithms and conception (B3), evaluation and validation (B4), legal, ethical, and economic issues (B5), and education (B6), and five major facilitators covering data (F1), clinical impact (F2), algorithms and conception (F3), evaluation and validation (F4), and education (F5).ConclusionThis scoping review highlighted the need to carefully design, deploy, and evaluate AI solutions in clinical practice, involving all stakeholders to yield improvement in healthcare.Clinical relevance statementThe identification of barriers and facilitators with suggested solutions can guide and inform future research, and stakeholders to improve the design and implementation of AI for breast cancer detection in clinical practice.Key Points & BULL; Six major identified barriers were related to data; black-box and trust; algorithms and conception; evaluation and validation; legal, ethical, and economic issues; and education.& BULL; Five major identified facilitators were related to data, clinical impact, algorithms and conception, evaluation and validation, and education.& BULL; Coordinated implication of all stakeholders is required to improve breast cancer diagnosis with AI.Key Points & BULL; Six major identified barriers were related to data; black-box and trust; algorithms and conception; evaluation and validation; legal, ethical, and economic issues; and education.& BULL; Five major identified facilitators were related to data, clinical impact, algorithms and conception, evaluation and validation, and education.& BULL; Coordinated implication of all stakeholders is required to improve breast cancer diagnosis with AI.Key Points & BULL; Six major identified barriers were related to data; black-box and trust; algorithms and conception; evaluation and validation; legal, ethical, and economic issues; and education.& BULL; Five major identified facilitators were related to data, clinical impact, algorithms and conception, evaluation and validation, and education.& BULL; Coordinated implication of all stakeholders is required to improve breast cancer diagnosis with AI.